Back to News & Events

Medisafe Secures $30M in Series C Funding to Build Future Model of Patient Support

Medisafe has raised $30 million in Series C funding with investments led by Sanofi Ventures and ALIVE Israel HealthTech Fund, joined by Leumi Partners, Menorah Mivtachim and Consensus Business Group, along with previous investors Pitango Ventures, 7Wire Ventures, Merck Ventures, Octopus Ventures, lool HealthTech, Triventures and Ourcrowd.

You may also like

Protected: Pfizer Demo by Medisafe Aug 6 025

There is no excerpt because this is a protected post.

..Read More

80% Pharma Price Cuts? A New Era of Performance-Driven Patient Engagement for Agencies

The second half of 2025 brings an increasingly pressurized pharmaceutical landscape marked by potential federal mandates to slash US drug 

..Read More

Transforming Breast Cancer Care: Proven Adherence Gains for Pharma Execs

Summary Breast cancer remains one of the most prevalent malignancies worldwide, with an estimated 287,850 new invasive cases and 43,250 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.

Contact Us